NIH launches trial of Zika vaccine candidate

A clinical trial to evaluate a candidate vaccine for Zika virus is underway, with preliminary results from the multisite phase I trial expected by the end of 2016. Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health,...
Source: Skin and Allergy News - Category: Dermatology Source Type: news